Bayer Crop Science Intrinsic Value
Bayer Crop Science intrinsic value. Bayer Crop Science (BAYERCROP) median intrinsic value is ₹1426.67 from 10 valuation models (range ₹670–₹4286), vs current price ₹3348.40 — -57.4% downside (Trading Above Calculated Value), margin of safety -100.0%. For current market price and key ratios, visit Bayer Crop Science share price chart.
BAYERCROP Valuation Methods Summary — DCF, Graham Number & P/E
Bayer Crop Science intrinsic value across 10 models vs current price ₹3348.40 — upside/downside and value range per method. Analyse Bayer Crop Science shareholding analysis to track promoter, FII and institutional holdings.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹1990.80 | ₹1592.64 - ₹2388.96 | -40.5% | EPS: ₹165.90, Sector P/E: 12x |
| Book Value Method | asset | ₹669.68 | ₹602.71 - ₹736.65 | -80.0% | Book Value/Share: ₹659.11, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹1004.52 | ₹904.07 - ₹1104.97 | -70.0% | Revenue/Share: ₹1212.89, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹1426.67 | ₹1284.00 - ₹1569.34 | -57.4% | EBITDA: ₹1070.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹3256.98 | ₹2605.58 - ₹3908.38 | -2.7% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹1061.76 | ₹955.58 - ₹1167.94 | -68.3% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹1335.15 | ₹1201.64 - ₹1468.67 | -60.1% | Revenue Growth: 1.2%, Adj P/E: 8.0x |
| ROE Based Valuation | profitability | ₹2652.44 | ₹2387.20 - ₹2917.68 | -20.8% | ROE: 25.2%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹1318.22 | ₹1186.40 - ₹1450.04 | -60.6% | EPS: ₹165.90, BVPS: ₹659.11 |
| Dividend Yield Method | dividend | ₹4285.71 | ₹3857.14 - ₹4714.28 | +28.0% | DPS: ₹150.00, Target Yield: 3.5% |
BAYERCROP Intrinsic Value vs Market Price — All Valuation Models
Bayer Crop Science fair value range ₹670–₹4286 vs current market price ₹3348.40 across 10 valuation models. Browse BAYERCROP cash flow statement for revenue, profit, balance sheet and cash flow data.
BAYERCROP Intrinsic Value Analysis — Undervalued or Overvalued?
Bayer Crop Science median intrinsic value ₹1426.67, current price ₹3348.40 — Trading Above Calculated Value by 57.4%, margin of safety -100.0%.
What is the intrinsic value of BAYERCROP?
Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Bayer Crop Science (BAYERCROP) is ₹1426.67 (median value). With the current market price of ₹3348.40, this represents a -57.4% variance from our estimated fair value.
The valuation range spans from ₹669.68 to ₹4285.71, indicating ₹669.68 - ₹4285.71.
Is BAYERCROP undervalued or overvalued?
Based on our multi-method analysis, Bayer Crop Science (BAYERCROP) appears to be trading above calculated value by approximately 57.4%.
BAYERCROP Financial Health — Key Ratios vs Industry Benchmarks
Bayer Crop Science financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | 25.2% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 17.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.96x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
BAYERCROP Cash Flow Quality — Operating & Free Cash Flow
Bayer Crop Science operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹1,079 Cr | ₹1,079 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹262 Cr | ₹262 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹952 Cr | ₹952 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹609 Cr | ₹609 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹216 Cr | ₹216 Cr | Positive Free Cash Flow | 8/10 |